Varian Medical Systems, Inc. VAR recently announced the launch of Ethos therapy, an adaptive intelligence solution, with a view to transform cancer care, globally. The latest development is expected ...

Palo Alto, Calif.-based Varian Medical Systems Inc. has won the U.S. FDA’s nod for its Ethos therapy, an artificial intelligence-driven holistic solution that aims to transform cancer care. This ...

PALO ALTO, Calif., Feb. 11, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Ethos ™ therapy, an Adaptive Intelligence ™ solution. Ethos therapy is ...

PALO ALTO, Calif., Sept. 10, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced the Goshen Center for Cancer Care in Goshen, Ind., treated its first patient with Ethos ™ therapy, marking the ...

Varian Medical Systems, Inc. VAR recently announced that it has received Germany’s first order of Ethos therapy from the German Cancer Research Center (DKFZ) in Heidelberg. Notably, the first Ethos ...

PALO ALTO, Calif., July 22, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new functionality to its ...

Varian Medical Systems, Inc. VAR recently announced that Goshen Center for Cancer Care in Goshen treated its first patient with Ethos Therapy. This marks the first availability of this advanced cancer ...

CLEVELAND – Radiation oncologists at UH Seidman Cancer Center have another powerful treatment option for patients diagnosed with many forms of cancer with the addition of Varian Ethos 2.0, capable of ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Varian, a Siemens Healthineers company, will showcase its commitment to delivering paradigm-shifting and integrated innovations to personalize the cancer care ...

PALO ALTO, Calif., Feb. 2, 2023 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well ...

Palo Alto, Calif.-based Varian Medical Systems Inc. has won the U.S. FDA’s nod for its Ethos therapy, an artificial intelligence (AI)-driven holistic solution that is aiming to transform cancer care.